A double blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients

Psychopharmacology

Volumn 127, Issue 3, 1996, Pages 231-237

  Bruijn, J A ^a   Moleman, P ^b   Mulder, P G H ^c   Van Den Broek, W W ^a   Van Hulst, A M ^a   Van Der Mast, R C ^a   Van De Wetering, B J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Moleman Research   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Antidepressant effect; Fixed blood level monitoring; Imipramine; In patients; Major depression; Mirtazapine; Study design

Indexed keywords

ANTIDEPRESSANT AGENT; HALOPERIDOL; IMIPRAMINE; LORAZEPAM; MIRTAZAPINE; VALERIAN;

ADULT; ALLERGIC REACTION; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG RESPONSE; FEMALE; HAMILTON SCALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SUICIDAL BEHAVIOR; SYMPTOM;

EID: 0029850633     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246131     Document Type: Article

References (23)

1. Angst J (1993) Severity of depression and benzodiazepine comedication in relationship to efficacy of antidepressants in acute trials. Hum Psychopharmacol 8: 401-407
2. Angst J, Bech P, Boyer P, Bruinvels J, Engel R, Heimchen H, Hippius H, Lingjaerde O, Racagni G, Saletu B, Sedvall G, Silverstone JT, Stelanis CN, Stoll K, Woggon (1989) Consensus conference on the methodology of clinical trials of antidepressants, Zurich, March 1988: report of the consensus committee. Pharmacopsychiatry 22: 3-7
3. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn. revised (DSM-III-R). The American Psychiatric Association Press, Washington DC
4. Ansseau M (1992) The Atlantic gap; clinical trials in Europe and the United States. Biol Psychiatry 31:109-111
5. Bech P (1988) A review of the antidepressant properties of serotonin re-uptake inhibitors. Adv Biol Psychiatry 17:58-69
6. Claghorn JL, Lesem MD (1995) A double-blind placebo controlled study of Org 3770 in depressed outpatients. J Affect Disord 34: 165-171
7. Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicentre study. Psychopharmacology 90:131-138
8. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicentre study. J Affect Disord 18:289-299
9. Dawling S (1988) Monitoring of tricyclic antidepressant therapy. Clin Biochem 15: 56-61
10. De Boer Th, Mauri G, Raiteri M, de Vos CJ, Wieringa J, Pinder RM (1988) Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, ORG 3770 and its enantiomers. Neuropharmacology 27:399-408
11. Hamilton M (1960) A rating scale for depression (HRS). J Neurol Neurosurg Psychiatry 23:56-61
12. 3 receptors in cultured mouse neuroblastoma cells. Neuropharmacology 33:501-510
13. Marttila M, Jaaskelainen J, Jarvi R, Romanov M, Miettinen E, Sorri P, Ahlfors U, Zivkov M (1995) A double-blind study comparing the efficacy and tolerability of Org 3770 and doxepin in patients with major depression. Eur Neuropsychopharmacol 5: 441-446
14. Montgomery SA, Asberg MA (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389
15. Paanakker JE, Van Hal HJM (1987) Capillary gas chromatographic assay for routine monitoring of the antidepressant meperzepine in human plasma. J Chromatogr 417:203-207
16. Perry PJ, Pfohl BM, Holstad SG (1987) The relationship between antidepressant response and tricyclic antidepressant plasma concentrations; a retrospective analysis of the literature using logistic regression analysis. Clin Pharmacokinet 13:381-391
17. Potter WZ, Rudorfer MV (1989) Antidepressants: a comparative review of the clinical pharmacology and the therapeutic use of the 'newer' versus the "older" drugs. Drugs 37:713-738
18. Richou H, Ruimy P, Charbaut J, Dclisle JP, Brunner H, Patris M, Zivkov M (1995) A multicentre, double-blind, clomipramine-controlled efficacy and safety study of Org 3770. Hum Psychopharmacol 10:263-271
19. Smith WT, Glaudin V, Panagides J, Gilvary E (1990) Mirtazapine vs amitriptyline vs placebo in the treatment of major depressive disorder. Psychopharmal Bull 26:191-196
20. Spitzer RL, Endicott J (1978/79) Schedule for affective disorders and schizophrenia (SADS). Research Assesment and Training Unit, Slate Psychiatric Institute, New York
21. Spitzer RL, Endicott J, Robins E (1978) Research diagnostic-criteria (RDC): rationale and reliability. Arch Gen Psychiatry 35:773-782
22. Van Moffaert M, De Wilde J, Vereecken A, Dierick M, Evrard JL, Wilmotte J, Mendlewicz J (1995) Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression. Int Clin Psychopharmacol 10:3-9
23. Zivkov M, De Jong G (1995) Org 3770 vs amitriptyline: a 6-week randomized double-blind multicentre trial in hospitalised depressed patients. Hum Psychopharmacol 10: 173-180